LINC00029: A Drug Target / Disease Biomarker (G100144596)

Target Name: LINC00029

NCBI ID: G100144596

LINC00029

Other Name(s): NCRNA00029 | Long intergenic non-protein coding RNA 29 | long intergenic non-protein coding RNA 29 | C20orf51

LINC00029: A Drug Target / Disease Biomarker

LINC00029 is a protein that is expressed in various tissues throughout the body. It is a key regulator of cell adhesion and has been implicated in a number of diseases, including cancer.

One of the key functions of LINC00029 is its role in cell adhesion. This protein helps to keep cells together, which is important for the development, maintenance, and repair of tissues. In addition, LINC00029 has been shown to play a role in the regulation of cell signaling pathways, which are the ways that cells communicate with one another.

LINC00029 is also involved in the regulation of cell division. It helps to control the number of cells that are produced by a cell, which is important for the growth and development of tissues. In addition, LINC00029 has been shown to be involved in the regulation of cell apoptosis, which is the process by which cells die.

In addition to its role in cell adhesion and division, LINC00029 has also been implicated in the development and progression of a number of diseases. For example, LINC00029 has been shown to be involved in the development of cancer, and it has also been associated with the development of a number of other diseases, including neurodegenerative disorders and autoimmune diseases.

Despite these promising findings, more research is needed to fully understand the role of LINC00029 in disease. In particular, it would be important to study the effects of LINC00029 on cell signaling pathways and its role in the regulation of cell division and apoptosis. Additionally, there would be be potential for the development of small molecule compounds that can inhibit the activity of LINC00029 and potentially treat diseases associated with its dysfunction.

Overall, LINC00029 is a protein that has the potential to be a drug target or biomarker. Further research is needed to fully understand its role in disease and the development of compounds that can inhibit its activity.

Protein Name: Long Intergenic Non-protein Coding RNA 29

The "LINC00029 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LINC00029 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets